Overview
Proteomics is a branch of biotechnology focused on the study of proteins. It is becoming increasingly important for the early detection of cancer due to the fact that proteins can act as biomarkers, providing information about the metabolism of cells in the body. Proteomic analysis can be used to identify and quantify different proteins in the blood and other bodily fluids, and can be used to detect cancer at its earliest stages and to monitor the progression of the disease. Proteomic-based methods can also be used to analyse the response to treatment and to develop more accurate ways to identify individuals with an increased risk of developing cancer. As such, proteomics is an essential tool for the early diagnosis, prognosis and treatment of cancer.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Human Proteome Project and Current Bioinformatics Status in Disease Diagnosis and Treatment
Determination of the Proteomic Response to Lapatinib Treatment using a Comprehensive and Reproducible Ion-Current-Based Proteomics Strategy
Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis
How this research is being cited
The 4 articles above have been cited 34 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Bioinformatics
-
2025 · Computational and Structural Biotechnology Journal
-
2025 · Journal of Molecular Structure
-
2025 · Journal of Molecular Structure
-
Cynthia Al Hageh et al. · 2025 · Computational and Structural Biotechnology Journal
-
2024 · Current Genomics
-
2024 · Lipids in Health and Disease
-
2024 · International Journal of Emerging Electric Power Systems
A sample of recent works citing this journal's research on Proteomic Applications for the Early Detection of Cancer, linking to each citing work.